Results of the Diabetes Control and Complications Trial (DDCT) suggest
that intensive therapy can prevent or delay the microvascular complic
ations of diabetes. This article critically appraises evidence from th
e DCCT and other prospective trials and concludes that the successful
results for persons with insulin-dependent diabetes cannot be generali
zed to most family practice diabetes patients, who have non-insulin-de
pendent diabetes.